Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.
Sarah M BartschColleen WeatherwaxMarie F MartinezKevin L ChinMichael R WassermanRaveena D SinghJessie L HeneghanGabrielle M GussinSheryl A ScannellCameron WhiteBruce LeffSusan S HuangBruce Y LeePublished in: Infection control and hospital epidemiology (2024)
SARS-CoV-2 testing costs outweighed benefits under winter 2023-2024 conditions; however, testing became cost-effective with increasingly severe clinical outcomes. Cost-effectiveness can change as the epidemic evolves because it depends on clinical severity and other intervention use. Thus, nursing home administrators and policy makers should monitor and evaluate viral virulence and other interventions over time.